Mr Arnaud Duhamel > Gide Loyrette Nouel A.A.R.P.I. > Paris, France > Lawyer Profile

Gide Loyrette Nouel A.A.R.P.I. houses an ‘efficient, experienced, dedicated’ team which handles a broad range of health data, patent infringement, and financing matters. Raphaëlle Dequiré-Portier is a key name for patent validity and infringement cases, in addition to SPC issues; Jean-Hyacinthe de Mitry has longstanding experience in unfair competition and trade secret protection work; and Emmanuel Larere is a seasoned patent litigator who often represents cosmetics clients in trade mark mandates. Arnaud Duhamel routinely advises investors and issuers on equity derivatives transactions, and capital markets expert Melinda Stege Arsouze has a strong focus on emerging markets, while Thierry Dor is knowledgeable about personal data law and AI projects. Dimitri Dimitrov is well equipped to handle merger notifications and distribution issues, while Anne Tolila often advises on M&A and divestment projects.

Gide Loyrette Nouel A.A.R.P.I.  regularly assists banks acting as underwriters, investors as well as some issuers with mid-cap transactions, spanning IPOs, share capital increases as well as convertibles and private placements, while also occasionally handling larger deals. The team is particularly active in the biotech sector where it handles a whole array of transactions including combined EU and US private placements. Key names in the practice include the highly experienced Arnaud Duhamel and US law expert Melinda Stege-Arsouze. Counsel Scott Logan  provides support. Of note, Guilhem Richard   and counsel Marie-Hélène Gryparis  left the firm in 2024.